November 8, 2026
Implement patient-reported outcomes (PROs) for patient-centered drug development
This course provides an overview of the key steps required to successfully implement patient-reported outcome (PRO) measurement within drug development programs. It focuses on generating evidence to support patient-centered value messaging across regulatory, reimbursement, and market access contexts.
Technical topics include:
- Selection, evaluation, and validation of PRO instruments
- Psychometric testing, data capture, and interpretation of PRO data
- Regulatory and payer expectations for qualitative and quantitative PRO evidence
- Determining meaningful change and the need for new instruments
This course includes tools and concepts that can be immediately applied, including:
- Practical frameworks for reviewing and selecting PRO measures
- Real-world case studies highlighting successful strategies and common pitfalls
- Interactive discussions on best practices for PRO implementation in clinical trials
Participants will gain the knowledge and skills required to take on a more active and confident role in PRO strategy and implementation.
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
LEVEL: Experienced
TRACK: Patient-Centered Research
FACULTY MEMBERS
Schedule:
LENGTH: 4 Hours | Course runs 1 day
Sunday, 8 November 2026 | Course runs 1 Day
1:00pm-5:00pm Central European Time (CET)
*Conference attendance is not required to attend an ISPOR Short Course. Separate registration is required for conference attendees.
Visit the ISPOR Europe 2026 Program page to view all short courses offered.